Market Place
Sourcing Support
US FDA grants IND clearance for Aston Sci.’s Phase II cancer vaccine trial
05 Sep 2022 //
CLINICALTRIALSARENA
Aston gets US FDA nod to begin PII trial of therapeutic cancer vaccine AST-301
04 Sep 2022 //
PHARMABIZ
Aston Receives IND Approval from U.S. FDA for Phase 2 Clinical Trial of AST-301
02 Sep 2022 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.